Ministry of Commerce: investigating "potential rules" of drug circulation

Source: on the morning of September 9, 2014, the members of "special investigation on the structural adjustment and fair competition environment of drug distribution industry" of the Ministry of Commerce held a meeting in the Ministry of Commerce to formally deploy and implement the investigation project plan The investigation covers five aspects, and the "potential rules" that hinder fair market competition are also within the scope of investigation It is reported that this survey mainly involves five aspects: first, it investigates the merger and reorganization of the national drug circulation industry since 2011, the overall situation and change trend of the industry's cross regional, cross ownership and cross industry structural adjustment The second is to investigate the background, effect and experience of major merger and reorganization cases, as well as the difficulties, problems and policy obstacles encountered by enterprises in the process of reorganization The third is to investigate the drug trading license held by large and medium-sized enterprise groups, and truly assess the severity of the industry's "many, small and scattered" problems Fourth, understand and verify the barriers, market segmentation, abuse of administrative power to intervene in the market and other policies and regulations restricting the formation of the national unified market in the aspects of registration, drug purchase and pricing, and the selection of distributors Fifthly, we should make clear the evaluation criteria of the policies that hinder the fair competition of the industry and the outstanding problems that need to be cleared up Qin Mai and cypress blue participated in the survey a few days ago, the Ministry of Commerce entrusted Beijing Taimai pharmaceutical consulting and cypress blue to cooperate with the Ministry of Commerce to carry out the above special investigation activities Cypress blue took the lead in sharing the "investigation on policies hindering fair competition in the pharmaceutical circulation industry": it will investigate and verify the barriers, market segmentation, abuse of administrative power to intervene in the market or lead to drug price distortion and other policies restricting the formation of the national unified market in the aspects of enterprise registration, drug purchase and pricing, selection of distributors, etc Regulations This is an important part of the five surveys According to the members of the investigation team, it is urgent to clean up the regulations, rules and regulations of governments and departments at all levels concerning the access of drugs to regional markets and the business conduct of pharmaceutical distribution enterprises as soon as possible, and to abolish the regulations and practices that hinder the national unified market and fair competition The Ministry of Commerce of the people's Republic of China launched such a survey in a timely manner, which will effectively promote fair competition and healthy development of the industry Industry "potential rules" included in the scope of investigation In the morning of the same day, when talking about the investigation of policies hindering fair competition, relevant officials of the Ministry of Commerce said that they should not only investigate those policy documents that affect fair competition in the market, but also some "hidden rules" that are not explicitly reflected in the words, but also seriously affect market fairness, and the investigation team should also conduct full investigation and investigation It is a great encouragement for the industry to clean up unreasonable policies But the key is that in local protection and departmental protection, some hidden rules are not clearly defined, but "invisible and intangible", and even sometimes the harm of such "hidden rules" to fair market competition is more serious than the clear rules In this regard, the newly released notice of six departments including the Ministry of Commerce on implementing the key tasks of 2014 medical reform to improve the service level and efficiency of drug circulation only proposed unreasonable policies and regulations that could be seen in the cleaning up, did not propose "potential rules" for cleaning up, nor even advocated "potential rules" for cleaning up.